5-HT2A receptor/5-HT1A receptor/dopamine receptor D2/SERT modulators (Suven)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT2A receptor/5-HT1A receptor/dopamine receptor D2/SERT modulators (Suven)
Drug Alias Namemultimodal compounds (Suven Life Sciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor modulatorsSerotonin 2a (5-HT2a) receptor modulatorsDopamine D2 receptor modulators +[4] 
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptorSerotonin 2a (5-HT2a) receptor +[4] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuven Life Sciences Ltd
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A